Firms
Theme

SLM

SLM Corporation · NASDAQ

$19.42USDCS band Mixed

↓ $2.35 (10.78%)

Last close · Oct 23, 4:00 PM ET

Sign up free to see this.

Mkt Cap
$3.7B
Volume
12.4M
52W High
$31.06
52W Low
$17.77
PE Ratio
5.1
Avg Vol
3M
As of 10/23/26
Div Yield
3.23%
Beta
1.09
As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about SLM?

Latest news

News ›

Zacks Investment Research

Seeking Clues to Sallie Mae (SLM) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Wall Street analysts forecast Sallie Mae will report Q3 earnings of $0.12 per share, representing an 81% year-over-year decline, with revenues expected at $353.66 million (down 5.2% YoY). Key metrics show declining performance across Net Interest Margin (4.9% vs 5.2%), Net Interest Income ($349.10M vs $372.98M), and Total Non-Interest Income ($102.97M vs $172.70M). The stock has declined 8.2% over the past month and carries a Zacks Rank #3 (Hold) rating.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $SLM · 0 threads

Sign in to post on $SLM

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev